Article Sidebar

Download
Statistic
Read Counter : 28

Main Article Content

Abstract

Outbreaks of diseases remain one of the most important challenges for the animal industry and public health. Throughout history, vaccination has played a fundamental role in the control and prevention of infectious diseases. However, the efficacy of vaccines needs to be continually reviewed, and their safety should be monitored. Recent advances in molecular biology have increased the possibility of creating new vaccines, such as DNA vaccines. Compared to conventional vaccines, DNA vaccines are safer, cheaper, and easier to maintain and transport. The present study aims to provide an overview of the current advancements in DNA vaccine technology, including their production mechanisms, applications, efficacy, and their advantages in disease prevention.

Keywords

Animal Health Antibiotics-Resistance Bacteria Dissemination Public Health Treatment

Article Details

License

Copyright (c) 2024 Reserved for Kabul University.

Creative Commons License

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.

How to Cite
Hakim, H. . (2020). The Way of Production, Application, and Efficacies of DNA Vaccines in the Prevention of Diseases. Journal of Natural Sciences – Kabul University, 3(1), 229–241. https://doi.org/10.62810/jns.v3i1.137
Download Citation
Endnote/Zotero/Mendeley (RIS)
BibTeX

References

  1. K. A. Smith, "Edward Jenner and the small pox vaccine," Front. Immunol. 2011. Avialable from https://doi.org/10.3389/fimmu.2011.00021
  2. S. Lakhani, “Early clinical pathologists: Edward Jenner (1749-1823)," J. Clin. Pathol, 1992. pp 756-758.
  3. Z. Zhang-Barber, A. K. Turner, and P. A. Barrow, "Vaccination for control of Salmonella in poultry," Vaccine, 1999. pp 2538-2545.
  4. D. Salk and J. Salk, "Vaccinology of poliomyelitis," Vaccine. 1984. pp 59-74.
  5. M. S. Kim, T. H. Lim, D. H. Lee, H. N. Youn, S. Yuk, B. Y. Kim, S. W. Choi, C. H. Jung, J. H. Han and C. S. Song, "An inactivated oil-emulsion fowl Adenovirus
  6. serotype 4 vaccine provides broad cross-protection against various serotypes of fowl Adenovirus," Vaccine, 2014. pp 3564-3568.
  7. W. J. McAleer, E. B. Buynak, R. Z. Maigetter, D. E. Wampler, W. J. Miller, and M. R. Hilleman, "Human hepatitis B vaccine from recombinant yeast," Nature, 1984. pp 178-180.
  8. M. R. Hilleman, "Yeast recombinant hepatitis B vaccine," Infection. 1987. pp 3-7.
  9. S. Plotkin, "History of vaccination," Proceedings the National Academy of Sciences of the United States of America. 2014. pp 12283-12287.
  10. P. Dubey and S. B. Mukherjee, "Vaccine preventable diseases," J. Intl. Med. Sci. Academy. 2004. Doi: 10.1201/b13526-10
  11. T. A. Free, "Epidemiology and Prevention of Vaccine-Preventable Diseases, Seventh Edition," Nurse Pract., 2003. Doi :00013-200302000-00006205/10.1097
  12. A.E. Birn, "Small (pox) success?" Cien. Saude Colet., 2011. pp 591-597.
  13. C. Plague, “Rinderpest Rinderpest," Organization, 2008. pp 1-5. Available from: https://www.mendeley.com/catalogue/rinderpest-rinderpest/
  14. S. Babiuk and L. A. Babiuk, “DNA Vaccines," in Encyclopedia of Virology, 2008. Doi: 10.1016/B978-012374410-4.00587-2.
  15. D. J. Shedlock and D. B. Weiner, "DNA vaccination: antigen presentation and the induction of immunity." J. Leukoc. Biol, 2000. pp 739-806.
  16. M. A. Kutzler and D. B. Weiner, "DNA vaccines: Ready for prime time?" Nat. Rev. Genet. 2008. pp 776-788.
  17. J. Heppell and H. L. Davis, “Application of DNA vaccine technology to aquaculture," Adv. Drug Deliv. Rev., 2000. pp 29-43.
  18. Bolhassani and S. R. Yazdi, "DNA immunization as an efficient strategy for vaccination." Aricenna J. Med. Biotechnol., 2009. pp 71-88.
  19. P. T. UIlas, A. Desai, and S. N. Madhusudana, "Rabies DNA Vaccines: Current Status and Future," World J. Vaccines, 2012. pp 36-45.
  20. E. Behzadi, R. Halabian, H. M. Hosseini, and A. A. I. Fooladi, "Bacterial toxin's DNA vaccine serves as a strategy for the treatment of cancer, infectious and autoimmune diseases," Microb. Pathog. 2016. pp 184-194.
  21. F. Ferrera, A. La Cava, M. Rizzi, B. H. Hahn, F. Indiveri, and G. Filaci, "Gene vaccination for the induction of immune tolerance," in Annals of the New York Academry of Sciences, 2007. pp 99-111.
  22. J. B. Alarcon, G. W. Waine, and D. P. McManus, "DNA vaccines: Technology and application as anti-parasite and anti-microbial agents," Adv. Parasitol. 1999. pp 343-410.
  23. M. Prince and M. T. Shata, "Immunoprophylaxis of hepatitis C virus infection," Clin. Liver Dis., 2001. pp 1091-1103.
  24. D. J. Laddy, J. Yan, N. Corbitt, D. Kobasa, G. P. Kobinger, and D. B. Weiner, "Immunogenicity of novel consensus-based DNA vaccines against avian influenza," Vaccine, 2007. pp 5128-5134.
  25. K. H. Khan, "DNA vaccines: Roles against diseases," Germs. 2013. pp 26-35.
  26. S. S. A. A. Hasson, J. K. Z. Al-Busaidi, and T. A. Sallam, “The past, current and future trends in DNA vaccine immunisations," Asian Pacific J. Trop. Biomed. 2015. pp 344-353.
  27. N. A. Doria-Rose and N. L. Haigwood, "DNA vaccine strategies: Candidates for immune modulation and immunization regimens," Methods, 2003. pp 207-216.
  28. H. S. Garmory, K. A. Brown, and R. Titball, "DNA vaccines: Improving expression of antigens," Genetic Vaccines and Therapy. 2003. Doi: 10.1186/1479- 0556.
  29. S. Gurunathan, D. M. Klinman, and R. A. Seder, "DNA Vaccines: Immunology, Application, and Optimization," Annu. Rev. Immunol., 2000. pp 927-974.
  30. R. Tuteja, “DNA vaccines: A ray of hope," Crit. Rev. in Bioch. Molec. Biol. 1999. pp 1-24.
  31. B. Yang, J. Jeang, A. Yang, T. C. Wu, and C. F. Hung, "DNA vaccine for cancer immunotherapy," Hum. Vaccines Immunother. 2014. pp 3153-3164.
  32. S. Gurunathan, C. Y. Wu, B. L. Freidag, and R. Seder, "DNA vaccines: A key for inducing long-term cellular immunity," Cur. Opin. Immunol. 2000. pp 442-447.
  33. H. L. Robinson and T. M. Pertmer, "DNA vaccines for viral infections: Basic studies and applications," Advan. Virus Res. 2000. pp 89-106.
  34. Y. Sun, Y. hua Hu, C. sheng Liu, and L. Sun, "Construction and analysis of an experimental Streptococcus iniae DNA vaccine," Vacine, 2010. pp 3905-3912.
  35. S. Sasaki, F. Takeshita, K. Q. Xin, N. Ishii, and K. Okuda, "Adjuvant formulations and delivery systems for DNA vaccines," Methods, 2003. pp 243-254.
  36. J. J. Donnelly, B. Wahren, and M. A. Liu, “DNA Vaccines: Progress and Challenges," J. Immunol, 2005. pp 633-639.
  37. M. A. Liu, "DNA vaccines: A review," J. Intern. Med. 2003. pp 402- 410.
  38. F. K. Stevenson et al, "DNA vaccines to attack cancer," Proc. Natl. Acad. SA. U. S. A., 2004. pp 14646-14652.
  39. T. J. Foster, "Potential for vaccination against infections caused by Staphylococcus aureus," Vaccine. 1991. pp 221-227.
  40. T. J. Kindt, R. A. Goldsby, and B. A. Osborne, "Kuby immunology, Sixth edition," in Immunology, 2007. ISBN-10: 1429202114
  41. D. Kim, C. F. Hung, T. C. Wu, and Y. M. Park, "DNA vaccine with a- galactosylceramide at prime phase enhances anti-tumor immunity after boosting with antigen-expressing dendritic cells," Vaccine, 2010. pp 7297-7305.
  42. P. Parham, "Elements of the Immune System and their Roles in Defense," Immune Syst., 2009. ISBN: 9780815341468
  43. Ø. Evensen and J. A. C. Leong, "DNA vaccines against viral diseases of farmed fish," Fish Shellfish Immunol., 2013. Doi: 10.3390/microorganisms7110569
  44. Y. Xu, P. W. Yuen, and J. K. W. Lam, "Intranasal DNA vaccine for protection against respiratory infectious diseases: The delivery perspectives," Pharmaceutics. 2014. pp 378-415.
  45. D. Fioretti, S. Iurescia, V. M. Fazio, and M. Rinaldi, “DNA vaccines: Developing new strategies against cancer," J. Biomed. Biotech. 2010. Doi: https://doi.org/ 10.1155/2010/174378
  46. L. Redding and D. B. Weiner, “DNA vaccines in veterinary use," Expert Rev. Vaccines. 2009. pp 1251-1276.
  47. K. Dhama, M. Mahendran, P. K. Gupta, and A. Rai, "DNA vaccines and their applications in veterinary practice: Current perspectives," Vet. Res. Comm. 2008. pp 341-356.